LBF20115PG03: Difference between revisions
No edit summary |
No edit summary |
||
(14 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1720 | |LipidBank=XPR1720 | ||
|LipidMaps=LMFA03010027 | |LipidMaps=LMFA03010027 | ||
|SysName=9alpha,11alpha- | |SysName=(9alpha,11alpha) -Dihydroxy-15-oxo-prost-cis-5-en-1-oic acid | ||
|Common Name=&&13,14-dihydro-15-keto Prostaglandin | |Common Name=&&13,14-dihydro-15-keto Prostaglandin F_2 alpha&&(9alpha,11alpha) -Dihydroxy-15-oxo-prost-5(Z)-en-1-oic acid&& | ||
|Source=13,14-dihydro-15-keto PGF2 alpha is the first prominent plasma metabolite of PGF2 alpha via PG 15-dehydrogenase pathway.[[Reference:Samuelsson_B:Goldyne_M:Granstrom_E:Hamberg_M:Hammarstrom_S:Malmsten_C:,Annu. Rev. Biochem.,1978,47,997|{{RelationTable/GetFirstAuthor|Reference:Samuelsson_B:Goldyne_M:Granstrom_E:Hamberg_M:Hammarstrom_S:Malmsten_C:,Annu. Rev. Biochem.,1978,47,997}}]] | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Latest revision as of 08:18, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1720 |
LipidMaps | LMFA03010027 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20115PG03 |
13,14-dihydro-15-keto Prostaglandin F2α | |
---|---|
Structural Information | |
(9α,11α) -Dihydroxy-15-oxo-prost-cis-5-en-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CCC(=O)CC[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
13,14-dihydro-15-keto PGF2 alpha is the first prominent plasma metabolite of PGF2 alpha via PG 15-dehydrogenase pathway. Samuelsson_B et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|